Balance Sheet
YOU ARE ON :
HOME
/
MARKETS
/
Company Information
/
Balance Sheet
Equity Analysis
Gainers & Losers
New Highs & Lows
52 Week High & Low
Advances & Declines
Top Value
Company Information
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Price Monthly
Intraday / EOD charts
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
De-Listed Shares
Market Turnover
Change Of Name
Split Of Face Value
News Analysis
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Corporate Results
Stock Alert
Pre-Session Commentary
Mid-Session Commentary
End-Session Commentary
Other Markets
ADR Prices
Initial Public Offering
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
Equity Analysis
Gainers & Losers
New Highs & Lows
52 Week High & Low
Advances & Declines
Top Value
Company Information
Detailed Quotes
Company Background
Board Of Directors
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Price Monthly
Intraday / EOD charts
Corporate Action
BSE Announcements
NSE Announcements
Board Meetings
Book Closure
Bonus Issues
Rights Issues
De-Listed Shares
Market Turnover
Change Of Name
Split Of Face Value
News Analysis
Hot Pursuit
Foreign Markets
Other Markets
Corporate News
Market Beat
Economy News
Corporate Results
Stock Alert
Pre-Session Commentary
Mid-Session Commentary
End-Session Commentary
Other Markets
ADR Prices
Initial Public Offering (IPO)
Forthcoming Issues
Open Issues
Closed Issues
New Listing
Basis of Allotment
Draft Prospectus
New Issue Monitor
Company Name :
Mangalam Drugs and Organics Ltd
Industry : (Pharmaceuticals)
BSE Code:
532637
NSE Symbol:
MANGALAM
P/E(TTM):
18.76
ISIN Demat:
INE584F01014
Div & Yield%:
-
EPS(TTM):
4.37
Book Value(₹):
93.92
Market Cap(₹Cr.):
129.76
Face Value(₹):
10.00
Mar '2024
Mar '2023
Mar '2022
Mar '2021
Mar '2020
SOURCES OF FUNDS :
Equity Share Capital
15.83
15.83
15.83
15.83
15.83
Reserves
126.52
136.13
134.73
114.96
88.11
Equity Share Warrants
0.00
0.00
0.00
0.00
0.00
Equity Application Money
0.00
0.00
0.00
0.00
0.00
Total Shareholders Funds
142.35
151.96
150.56
130.79
103.94
Secured Loans
90.29
74.42
78.39
62.55
49.78
Unsecured Loans
15.35
14.13
9.52
7.16
2.20
Total Debt
105.64
88.55
87.91
69.71
51.98
Other Liabilities
3.27
2.29
3.94
0.00
0.00
Total Liabilities
251.26
242.80
242.41
200.50
155.92
APPLICATION OF FUNDS :
Gross Block
254.50
236.91
220.30
196.69
170.92
Less: Accumulated Depreciation
107.20
94.54
85.34
78.88
69.85
Less:Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
147.30
142.37
134.96
117.81
101.07
Lease Adjustments
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
7.74
9.49
5.71
6.35
1.24
Investments
0.03
0.00
0.00
0.22
0.22
Current Assets, Loans & Advances
Inventories
123.64
137.47
117.11
58.59
64.84
Sundry Debtors
27.94
46.53
46.49
54.31
39.98
Cash and Bank Balance
1.01
1.04
1.95
0.59
1.63
Loans and Advances
47.19
18.22
19.48
20.43
12.72
Total Current Assets
199.78
203.26
185.03
133.92
119.17
Less : Current Liabilities and Provisions
Current Liabilities
92.81
98.95
69.25
49.03
61.64
Provisions
0.99
1.72
3.27
0.40
0.83
Total CL & Provisions
93.80
100.67
72.52
49.44
62.46
Net Current Assets
105.98
102.60
112.51
84.49
56.71
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets
0.00
0.00
0.73
1.11
0.33
Deferred Tax Liability
12.09
14.52
14.23
15.29
12.62
Net Deferred Tax
-12.09
-14.52
-13.50
-14.18
-12.29
Other Assets
2.29
2.86
2.72
5.79
8.96
Total Assets
251.25
242.79
242.40
200.49
155.91
Contingent Liabilities
7.18
26.43
45.81
9.61
7.28